Adverse birth outcome and associated factors among pregnant women managed by magnesium sulphate in Hiwot Fana Comprehensive Specialized University Hospital, Harari regional state, Eastern Ethiopia

Abstract

Magnesium sulphate has a long history of use in obstetrics. It is supported as the first line treatment for women with eclampsia and is the drug of choice for women with severe pre-eclampsia. In Ethiopia, magnesium sulphate is introduced as anticonvulsant for treatment of severe pre-eclampsia and eclampsia and has been introduced into the National Drug List of Ethiopia and is being used for prevention and treatment of severe pre-eclampsia and eclamptic seizures since January 2011 in public hospitals. However, there are no enough studies done to assess birth outcome and associated factors among women managed by MgSO4 in public hospitals in Ethiopia in general and in Hiwot Fana Specialized University Hospital in particular.